Skip to main content

Want a detailed portfolio tracker?

MAIA Biotechnology (MAIA) P/E (2022 - 2026)

MAIA Biotechnology (MAIA) P/E from Jul 28, 2022 to Jul 21, 2026. The TTM MAIA Biotechnology (MAIA) P/E is -2.13. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of MAIA Biotechnology (MAIA)

YearP/EChange
2026-2.13-6.43%
2025-2.27+16.73%
2024-1.95+150.96%
2023-0.78-71.48%
2022-2.72N/A

Comparison MAIA Biotechnology (MAIA) P/E with competitors

MAIA Biotechnology (MAIA) P/E is -2.13.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.08%
NBYStablecoin Development Corp0.00-100.20%
ENLVEnlivex Ltd0.07-103.52%
FGENFibroGen Inc0.24-111.29%
CHRSCoherus Biosciences Inc0.85-139.90%
FBIOFortress Biotech Inc0.95-144.63%
ORMPOramed Pharmaceuticals Inc1.50-170.68%
AGENAgenus Inc3.01-241.53%
INVAInnoviva Inc3.15-248.32%
VXRTVaxart Inc3.55-266.93%
CRMDCorMedix Inc3.63-270.63%
CVACCureVac N.V.4.45-309.06%
GLPGGalapagos NV4.86-328.49%
SRPTSarepta Therapeutics Inc4.88-329.58%
ABEOAbeona Therapeutics Inc5.39-353.35%
ABUSArbutus Biopharma Corp5.60-363.13%
ZVRAZevra Therapeutics Inc5.89-376.84%
SPROSpero Therapeutics Inc6.23-392.89%
CGENCompugen Ltd6.31-396.91%
RIGLRigel Pharmaceuticals6.87-423.16%
SLXNSilexion Therapeutics Corp7.30-443.10%
OMEROmeros Corporation9.26-535.39%
AUPHAurinia Pharmaceuticals Inc9.58-550.73%
PLXProtalix BioTherapeutics Inc10.89-612.15%
ACADAcadia Pharmaceuticals Inc11.73-651.53%
TBPHTheravance Biopharma Inc12.26-676.62%
ADMAAdma Biologics Inc12.42-683.96%
HRMYHarmony Biosciences Holdings Inc13.82-749.89%
SABSSAB Biotherapeutics Inc14.14-764.75%
NAGENiagen Bioscience Inc14.82-796.82%
INCYIncyte Corp15.82-844.05%
REGNRegeneron Pharmaceuticals Inc15.86-845.66%
PBYIPuma Biotechnology Inc17.32-914.27%
CPRXCatalyst Pharmaceuticals Inc17.44-920.08%
EXELExelixis Inc17.54-924.72%
TGTXTG Therapeutics Inc18.97-991.88%
MDXGMimedx Group Inc20.55-1066.48%
XOMAXOMA Royalty Corp22.87-1175.71%
ARGXArgen X SE24.30-1242.64%
CTMXCytomX Therapeutics Inc24.82-1267.24%
XOMAOXOMA Royalty Corp25.34-1291.87%
HALOHalozyme Therapeutics Inc25.62-1304.98%
XOMAPXOMA Royalty Corp25.67-1307.16%
VRTXVertex Pharmaceuticals Inc27.99-1416.48%
RPRXRoyalty Pharma plc - Class A28.69-1449.06%
SLNOSoleno Therapeutics Inc29.02-1464.48%
ASNDAscendis Pharma A/S30.09-1514.81%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1882.85%
APLSApellis Pharmaceuticals Inc39.02-1935.02%
BMRNBiomarin Pharmaceutical Inc42.21-2085.06%
KRYSKrystal Biotech Inc45.34-2232.33%
ONCBeiGene Ltd69.54-3370.22%
PHARPharming Group N.V.75.03-3628.16%
TECHBio-Techne Corp101.96-4894.71%
VCELVericel Corp109.92-5269.17%
ALNYAlnylam Pharmaceuticals Inc117.96-5647.44%
GMABGenmab140.29-6697.33%
TLXTelix Pharmaceuticals Ltd162.15-7725.42%
CORTCorcept Therapeutics Inc212.86-10109.86%